PM
66
2
HRL
51
4
TXT
55
2
ECL
62
2
APA
30
3
LH
46
-2
DRI
60
2
DVN
31
10
PBI
66
-2
PNC
65
-2
HPE
42
2
SO
62
-2
BF.B
37
2
SLB
56
3
ITW
67
3
BLK
55
-2
HCA
48
2
T
51
-2
SJM
19
-12
PSA
61
-2
PM
66
2
HRL
51
4
TXT
55
2
ECL
62
2
APA
30
3
LH
46
-2
DRI
60
2
DVN
31
10
PBI
66
-2
PNC
65
-2
HPE
42
2
SO
62
-2
BF.B
37
2
SLB
56
3
ITW
67
3
BLK
55
-2
HCA
48
2
T
51
-2
SJM
19
-12
PSA
61
-2
Financhill
Back

Invesco S&P 500® Equal Weight Fincl ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
70

RSPF
Invesco S&P 500® Equal Weight Fincl ETF

Last Price:
78.12
Seasonality Move:
3.85%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Buy
70
Invesco S&P 500® Equal Weight Fincl ETF (RSPF) is a Buy

Is Invesco S&P 500® Equal Weight Fincl ETF a Buy, Sell or Hold?

  • The current Invesco S&P 500® Equal Weight Fincl ETF [RSPF] share price is $78.05. The Score for RSPF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • RSPF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RSPF Stock Price Chart

What is Invesco S&P 500® Equal Weight Fincl ETF's stock price today?

  • The Invesco S&P 500® Equal Weight Fincl ETF share price today is $78.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSPF is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RSPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.65 Buy
Relative Strength Index (14 RSI): 74.48 Buy
Chaikin Money Flow: -530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.91 - 76.89) Buy
Bollinger Bands (100): (65.04 - 73.1) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

RSPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.79 Buy
20-day SMA: 75.15 Buy
50-day SMA: 72.24 Buy
200-day SMA: 65.34 Buy
8-day EMA: 77.02 Buy
20-day EMA: 75.44 Buy
50-day EMA: 72.75 Buy
200-day EMA: 66.12 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Invesco S&P 500® Equal Weight Fincl ETF Earnings Growth & RSPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Invesco S&P 500® Equal Weight Fincl ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):